ApoVax, Inc. — Form D
ApoVax, Inc. of LOISVILLE, KY, a company, filed a Form D exempt-offering notice with the SEC on 2012-11-26. The offering totals $500K, of which $125K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2012-11-26
- Form: D
- Accession: 0000911959-12-000036
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $500K
- Amount sold: $125K
- Remaining: $375K
- Minimum investment: $25K
- Investors: 1
- Date of first sale: 2012-11-13
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-187427
Issuer
- Name: ApoVax, Inc.
- CIK: 0001329338
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1044 EAST CHESTNUT ST, LOISVILLE, KY, 40204
- Phone: 502-212-2493
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael J Curtin | Director | Louisville, KY |
| George R Emont | Director | Louisville, KY |
| Steven R Gailar | Director | Louisville, KY |
| Haval J Shirwan | Director | Louisville, KY |
| George R Emont | Executive Officer | Louisville, KY |
| Steven R Gailar | Executive Officer | Louisville, KY |
| Haval J Shirwan | Executive Officer | Louisville, KY |
| Haval R Shirwan | Director | Louisville, KY |
Other filings by this issuer (2)
More